Putnam Investments’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-20,488
Closed -$388K – 1320
2016
Q4
$388K Buy
20,488
+307
+2% +$5.89K ﹤0.01% 1155
2016
Q3
$447K Sell
20,181
-27,031
-57% -$508K ﹤0.01% 1140
2016
Q2
$863K Sell
47,212
-963
-2% -$16.6K ﹤0.01% 1125
2016
Q1
$876K Buy
48,175
+1,014
+2% +$16.4K ﹤0.01% 1138
2015
Q4
$795K Sell
47,161
-713
-1% -$12.1K ﹤0.01% 1205
2015
Q3
$863K Buy
47,874
+1,518
+3% +$33.8K ﹤0.01% 1205
2015
Q2
$1.2M Buy
+46,356
New +$1.17M ﹤0.01% 1185

Other funds holding ENTL

Putnam Investments's ENTL Position: Q1 2017 in Review

Putnam Investments sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2017, closing a stake of 20,488 shares — an estimated $388K sold.

Putnam Investments first reported a position in ENTL in Q2 2015 and held it in 7 quarters. The position peaked at $1.2M in Q2 2015. 69 funds tracked by Wall St. Rank hold ENTL as of Q1 2017.

  • Putnam Investments reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Putnam Investments sold 20,488 Entellus Medical, Inc. Common Stock shares in Q1 2017, an estimated $388K.
  • Putnam Investments first reported a position in Entellus Medical, Inc. Common Stock in Q2 2015 and held it in 7 quarters.
  • Putnam Investments's Entellus Medical, Inc. Common Stock position peaked at $1.2M in Q2 2015.
  • 69 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2017.

Based on Putnam Investments's 13F filing for Q1 2017, filed 15 May 2017.